Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference
ALHAMBRA, Calif., Dec. 21, 2023 /PRNewswire/ — Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), a leading provider-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that leadership is participating in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Wednesday, January 10, 2024, including a presentation at 1:30 p.m. PT.
Related news for (AMEH)
- Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call
- ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership
- Apollo Medical Holdings, Inc. Announces Leadership Transitions
- Apollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana Health
- Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)